Pradaxa 110mg is an anticoagulant medication containing the active ingredient dabigatran etexilate formulated as capsules. It inhibits thrombin to prevent dangerous blood clots.
Uses
Pradaxa is prescribed to reduce stroke risk in non-valvular atrial fibrillation patients. It also treats and prevents recurrence of dangerous blood clots like deep vein thrombosis or pulmonary embolism.
Benefits
Key benefits of appropriately taking Pradaxa as prescribed include reduced chance of debilitating or fatal strokes due to uncontrolled atrial fibrillation, as well as prevention of painful and life-threatening deep clots.
Mechanism of Action
Dabigatran works by binding to and inhibiting the activity of thrombin, an enzyme central to blood coagulation. This anticoagulant effect lowers the risks of abnormal dangerous clots.
Dosage
The typical Pradaxa 110mg dosage for nonvalvular a-fib patients is 110mg twice per day. For clot prevention/treatment, it is initially given twice daily after parenteral anticoagulation. Duration depends on risk profiles.
Warnings
- Increased bleeding risk
- Kidney dysfunction requires dose adjustments
- Capsules should not be opened/sprinkled
Important Information
- Requires regular monitoring of renal function
- Other drugs can interact – consult physician
- Stopping should always be under medical guidance
Reviews
There are no reviews yet.